​

Funding Round

Series A - Auxilius

Series A - Auxilius

Investment Firm

Overview

Auxilius provides clinical trial financial management software for Biopharma.

Announced Date

Jun 16, 2022

Funding Type

Series A

Highlights

Location

New York, United States, North America

Social

Investor Lead

Renegade Partners

Renegade Partners

Renegade Partners is a early_stage_venture and late_stage_venture firm.

Participant Investors

5

Investor Name
Participant InvestorChase Gilbert
Participant InvestorSamuel Whitaker
Participant InvestorAndy Palmer
Participant InvestorRenegade Partners
Participant InvestorBain Capital Ventures

Round Details and Background

Auxilius raised $10000000 on 2022-06-16 in Series A

Auxilius provides clinical trial financial management software for Biopharma.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 16, 2022
Series A - Auxilius
6-10.0M
Mar 15, 2024
Series A - Auxilius
1-10.0M

Recent Activity

There is no recent news or activity for this profile.